Clinical reference
Antimigraine · Antimigraine agent, selective serotonin (5-HT1) agonist · Neurology
Zolmitriptan is a triptan for acute migraine. Formulations: tablets 2.5 mg (scored), 5 mg; oral disintegrating tablets (ODT) 2.5, 5 mg (contain aspartame); nasal spray 2.5 mg and 5 mg single-unit. Previously available as Zomig ZMT. Safety of >4 headaches in 30 days (nasal) or >3 (oral) not established. Use not recommended in moderate/severe hepatic impair…